CN102770440A - 纯化肽的制备性rp-hplc方法 - Google Patents

纯化肽的制备性rp-hplc方法 Download PDF

Info

Publication number
CN102770440A
CN102770440A CN2011800118239A CN201180011823A CN102770440A CN 102770440 A CN102770440 A CN 102770440A CN 2011800118239 A CN2011800118239 A CN 2011800118239A CN 201180011823 A CN201180011823 A CN 201180011823A CN 102770440 A CN102770440 A CN 102770440A
Authority
CN
China
Prior art keywords
peptide
value
polypeptide
glp
gradient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800118239A
Other languages
English (en)
Chinese (zh)
Inventor
X.吴
A.博格斯内斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of CN102770440A publication Critical patent/CN102770440A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2011800118239A 2010-03-01 2011-03-01 纯化肽的制备性rp-hplc方法 Pending CN102770440A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10155023.4 2010-03-01
EP10155023 2010-03-01
US30964210P 2010-03-02 2010-03-02
US61/309642 2010-03-02
PCT/EP2011/052964 WO2011107447A1 (en) 2010-03-01 2011-03-01 Preparative rp-hplc method for purifying peptides

Publications (1)

Publication Number Publication Date
CN102770440A true CN102770440A (zh) 2012-11-07

Family

ID=42727392

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800118239A Pending CN102770440A (zh) 2010-03-01 2011-03-01 纯化肽的制备性rp-hplc方法

Country Status (5)

Country Link
US (1) US9422330B2 (enExample)
EP (1) EP2542565A1 (enExample)
JP (1) JP5992836B2 (enExample)
CN (1) CN102770440A (enExample)
WO (1) WO2011107447A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104994924A (zh) * 2013-01-29 2015-10-21 诺伊兰健康科学私人有限公司 使用在反相柱上的替代固定相纯化有机化合物
CN105223296A (zh) * 2015-10-16 2016-01-06 江苏开元医药化工有限公司 一类多肽的纯化方法

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012313045A1 (en) * 2011-09-22 2014-04-10 Hochschule Ostwestfalen-Lippe Method for producing peptide fractions and use thereof
US8921113B2 (en) 2012-12-21 2014-12-30 Dionex Corporation Buffer kit and method of generating a linear pH gradient
EP2976331B1 (en) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthesis of hydantoin containing peptide products
MX365465B (es) 2013-03-21 2019-06-04 Sanofi Aventis Deutschland Sintesis de productos peptidicos que contienen imida ciclica.
CA2924821A1 (en) * 2013-09-20 2015-03-26 Davuluri, Ramamohan Rao Purification of organic compounds by surfactant mediated preparative hplc
EP3433268B1 (en) 2016-03-23 2021-07-28 Bachem Holding AG Purification of glucagon-like peptide 1 analogs
US12269844B2 (en) 2019-03-25 2025-04-08 Scinopharm Taiwan, Ltd. Process for purifying semaglutide and liraglutide
TWI738260B (zh) 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
US11022585B2 (en) 2019-06-09 2021-06-01 Dionex Corporation Methods and systems for optimizing buffer conditions with liquid chromatography
KR102691149B1 (ko) 2021-01-20 2024-08-05 바이킹 테라퓨틱스 인코포레이티드 대사 및 간 질환 치료를 위한 조성물 및 방법
CN115703825B (zh) * 2021-08-17 2026-01-02 派格生物医药(杭州)股份有限公司 艾塞那肽变体及其聚乙二醇缀合物的制备方法
US12421282B2 (en) 2021-09-15 2025-09-23 Viking Therapeutics, Inc. Compositions and methods for the treatment of metabolic and liver disorders
CN114656550A (zh) * 2021-12-28 2022-06-24 深圳翰宇药业股份有限公司 一种利拉鲁肽/索马鲁肽的纯化方法及应用
WO2024147150A1 (en) * 2023-01-02 2024-07-11 Zelle Biotechnology Pvt. Ltd. Chromatographic detection, estimation and separation of amino acids in hydrolysates of monoclonal antibodies

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232470A (zh) * 1996-08-30 1999-10-20 诺沃挪第克公司 Glp－1衍生物
CN1839155A (zh) * 2003-08-21 2006-09-27 诺沃挪第克公司 胰高血糖素样肽的纯化

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4028120C2 (de) * 1990-09-05 1996-09-19 Hoechst Ag Verfahren zur Reinigung von Insulin und/oder Insulinderivaten
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
US6767887B1 (en) 1996-06-05 2004-07-27 Roche Diagnostics Gmbh Exendin analogues, processes for their preparation and medicaments containing them
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
JP2007526235A (ja) 2003-08-21 2007-09-13 ノボ　ノルディスク　アクティーゼルスカブ グルカゴン様ペプチドの精製
WO2007071768A1 (en) 2005-12-23 2007-06-28 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (rpc)
WO2007071767A1 (en) 2005-12-23 2007-06-28 Novo Nordisk Health Care Ag Purification of vitamin k-dependent polypeptides using preparative reverse phase chromatography (rpc)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1232470A (zh) * 1996-08-30 1999-10-20 诺沃挪第克公司 Glp－1衍生物
CN1839155A (zh) * 2003-08-21 2006-09-27 诺沃挪第克公司 胰高血糖素样肽的纯化

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KALISZAN R ET AL: "pH gradient reversed-phase HPLC", 《ANALYTICAL CHEMISTRY》 *
TOMASZ BACZEK ET AL: "pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides", 《TALANTA》 *
WICZLING P ET AL: "Determination of PKa by pH gradient reversed-phase HPLC", 《ANALYTICAL CHEMISTRY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104994924A (zh) * 2013-01-29 2015-10-21 诺伊兰健康科学私人有限公司 使用在反相柱上的替代固定相纯化有机化合物
CN105223296A (zh) * 2015-10-16 2016-01-06 江苏开元医药化工有限公司 一类多肽的纯化方法

Also Published As

Publication number Publication date
JP5992836B2 (ja) 2016-09-14
WO2011107447A1 (en) 2011-09-09
EP2542565A1 (en) 2013-01-09
US9422330B2 (en) 2016-08-23
JP2013521485A (ja) 2013-06-10
US20120322976A1 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
CN102770440A (zh) 纯化肽的制备性rp-hplc方法
JP7011643B2 (ja) グルカゴン様ペプチド１類似体の精製
JP5755398B2 (ja) 伸長されたｇｌｐ−１化合物
JP4585037B2 (ja) アシル化ｇｌｐ−１化合物
JP6179864B2 (ja) グルカゴン／ｇｌｐ−１レセプタコ−アゴニスト
JP5756407B2 (ja) ポリペプチドの向流精製
KR102002783B1 (ko) 포도당 의존성 인슐리노트로핀 폴리펩타이드 유사물질, 이의 약학적 조성물 및 응용
CN101868476B (zh) 胰高血糖素样肽-1衍生物及其制药用途
EP2464655B1 (en) Chromatographic processes
US20110313131A1 (en) Reversed phase hplc purification of a glp-1 analogue
JP6110312B2 (ja) インスリンの精製
MXPA06006746A (es) Analogos de glp-1 novedosos ligados a agentes similares a albumina.
EP4095149A1 (en) Triple agonist for glucagon-like peptide-1 receptor, glucagon receptor, and gastric inhibitory polypeptide receptor
EP2905289A1 (en) Method for purifying teriparatide (PTH1-34)
CA3018627C (en) Purification of glucagon-like peptide 1 analogs
CA2908295A1 (en) Method for purifying teriparatide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20121107

RJ01 Rejection of invention patent application after publication